Kenneth Edwards Westerman, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Epigenomics | 2 | 2020 | 943 | 0.900 |
Why?
|
DNA Methylation | 4 | 2020 | 4399 | 0.830 |
Why?
|
Genome-Wide Association Study | 13 | 2024 | 12690 | 0.710 |
Why?
|
Vitamin K 1 | 1 | 2020 | 47 | 0.690 |
Why?
|
Diet | 4 | 2023 | 8075 | 0.680 |
Why?
|
Food Analysis | 1 | 2020 | 103 | 0.680 |
Why?
|
Cardiovascular Diseases | 5 | 2022 | 15502 | 0.590 |
Why?
|
Biological Specimen Banks | 2 | 2023 | 783 | 0.550 |
Why?
|
Diabetes Mellitus, Type 2 | 9 | 2024 | 12149 | 0.470 |
Why?
|
Quantitative Trait Loci | 1 | 2022 | 2116 | 0.450 |
Why?
|
Epigenesis, Genetic | 3 | 2020 | 3801 | 0.400 |
Why?
|
Dietary Fats | 1 | 2020 | 1995 | 0.400 |
Why?
|
Vitamins | 1 | 2020 | 1635 | 0.380 |
Why?
|
Gene Regulatory Networks | 1 | 2019 | 1745 | 0.360 |
Why?
|
Nutritional Status | 1 | 2018 | 1615 | 0.340 |
Why?
|
Genetic Testing | 1 | 2020 | 3537 | 0.280 |
Why?
|
Life Style | 1 | 2018 | 3917 | 0.270 |
Why?
|
Genetic Predisposition to Disease | 5 | 2024 | 17904 | 0.270 |
Why?
|
Diet, Vegetarian | 2 | 2024 | 180 | 0.250 |
Why?
|
CpG Islands | 2 | 2020 | 1230 | 0.240 |
Why?
|
Diabetes Mellitus | 1 | 2023 | 5841 | 0.240 |
Why?
|
Guanine Nucleotide Dissociation Inhibitors | 1 | 2023 | 23 | 0.220 |
Why?
|
Software | 3 | 2022 | 4434 | 0.210 |
Why?
|
Genetic Loci | 2 | 2020 | 2632 | 0.180 |
Why?
|
Polymorphism, Single Nucleotide | 7 | 2024 | 15936 | 0.170 |
Why?
|
Phenotype | 4 | 2024 | 16592 | 0.150 |
Why?
|
Blood Chemical Analysis | 1 | 2018 | 437 | 0.140 |
Why?
|
Prediabetic State | 1 | 2022 | 545 | 0.140 |
Why?
|
Blood Cells | 1 | 2018 | 305 | 0.140 |
Why?
|
Eating | 1 | 2023 | 1539 | 0.130 |
Why?
|
Fasting | 1 | 2022 | 1603 | 0.130 |
Why?
|
Glomerular Filtration Rate | 1 | 2024 | 2178 | 0.130 |
Why?
|
Humans | 22 | 2024 | 761596 | 0.120 |
Why?
|
Data Interpretation, Statistical | 2 | 2023 | 2691 | 0.120 |
Why?
|
Cell Count | 1 | 2018 | 1835 | 0.120 |
Why?
|
Membrane Transport Proteins | 1 | 2020 | 1035 | 0.110 |
Why?
|
Middle Aged | 10 | 2024 | 220921 | 0.110 |
Why?
|
Genetic Markers | 1 | 2020 | 2601 | 0.110 |
Why?
|
Predictive Value of Tests | 2 | 2020 | 15266 | 0.110 |
Why?
|
Cholesterol, HDL | 1 | 2020 | 1814 | 0.110 |
Why?
|
Testosterone | 1 | 2024 | 2472 | 0.110 |
Why?
|
Leukocytes, Mononuclear | 1 | 2020 | 1844 | 0.110 |
Why?
|
Female | 11 | 2024 | 392705 | 0.110 |
Why?
|
Triglycerides | 1 | 2020 | 2461 | 0.100 |
Why?
|
Plaque, Atherosclerotic | 1 | 2023 | 1532 | 0.100 |
Why?
|
Incidence | 2 | 2020 | 21355 | 0.100 |
Why?
|
Calcium | 1 | 2024 | 5722 | 0.090 |
Why?
|
Cholesterol, LDL | 1 | 2020 | 2382 | 0.090 |
Why?
|
Women's Health | 1 | 2020 | 2065 | 0.090 |
Why?
|
Male | 9 | 2024 | 360846 | 0.090 |
Why?
|
Aged | 6 | 2024 | 169310 | 0.080 |
Why?
|
Cohort Studies | 3 | 2023 | 41495 | 0.080 |
Why?
|
Coronary Disease | 1 | 2023 | 5914 | 0.080 |
Why?
|
Risk Assessment | 2 | 2020 | 23996 | 0.080 |
Why?
|
Feeding Behavior | 1 | 2020 | 3188 | 0.070 |
Why?
|
Atherosclerosis | 1 | 2023 | 3407 | 0.070 |
Why?
|
Genotype | 1 | 2022 | 12990 | 0.070 |
Why?
|
Multivariate Analysis | 1 | 2020 | 12059 | 0.070 |
Why?
|
Cluster Analysis | 2 | 2022 | 2707 | 0.060 |
Why?
|
Blood Pressure | 1 | 2020 | 8481 | 0.060 |
Why?
|
Hepatocyte Nuclear Factor 4 | 1 | 2024 | 126 | 0.060 |
Why?
|
Coronary Artery Disease | 1 | 2023 | 6403 | 0.060 |
Why?
|
Prevalence | 1 | 2020 | 15733 | 0.050 |
Why?
|
Putrescine | 1 | 2022 | 42 | 0.050 |
Why?
|
Acetylgalactosamine | 1 | 2022 | 38 | 0.050 |
Why?
|
Taurine | 1 | 2022 | 93 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2018 | 14608 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2020 | 20100 | 0.050 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2022 | 322 | 0.050 |
Why?
|
Prospective Studies | 2 | 2023 | 54423 | 0.040 |
Why?
|
Glucose | 2 | 2022 | 4347 | 0.040 |
Why?
|
Sample Size | 1 | 2023 | 841 | 0.040 |
Why?
|
Adult | 4 | 2024 | 221210 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2020 | 11461 | 0.040 |
Why?
|
Diet, Reducing | 1 | 2022 | 485 | 0.040 |
Why?
|
Norway | 1 | 2020 | 499 | 0.040 |
Why?
|
Gene Frequency | 1 | 2024 | 3606 | 0.040 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2020 | 262 | 0.040 |
Why?
|
Dietary Proteins | 1 | 2022 | 952 | 0.040 |
Why?
|
Workflow | 1 | 2022 | 851 | 0.040 |
Why?
|
Receptors, Immunologic | 1 | 2022 | 1410 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2024 | 1387 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2024 | 1899 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2020 | 58984 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2022 | 2330 | 0.030 |
Why?
|
Hematopoiesis | 1 | 2023 | 2050 | 0.030 |
Why?
|
Genome | 1 | 2022 | 1740 | 0.030 |
Why?
|
Metabolomics | 1 | 2022 | 1659 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2020 | 3779 | 0.020 |
Why?
|
Weight Loss | 1 | 2022 | 2684 | 0.020 |
Why?
|
Vitamin D | 1 | 2024 | 3303 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2022 | 4415 | 0.020 |
Why?
|
Genetic Variation | 1 | 2024 | 6567 | 0.020 |
Why?
|
Models, Statistical | 1 | 2023 | 5079 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5821 | 0.020 |
Why?
|
Insulin | 1 | 2022 | 6597 | 0.020 |
Why?
|
Exercise | 1 | 2023 | 5890 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2024 | 22176 | 0.020 |
Why?
|
Risk Factors | 2 | 2024 | 74213 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2020 | 9420 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10212 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 11904 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 12947 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 26129 | 0.010 |
Why?
|
Mutation | 1 | 2023 | 30053 | 0.010 |
Why?
|
United States | 1 | 2022 | 72340 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 59260 | 0.010 |
Why?
|